Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

ClinicalTrials.gov ID: NCT05327127

Public ClinicalTrials.gov record NCT05327127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Participants With Noncirrhotic Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).

Study identification

NCT ID
NCT05327127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kowa Research Institute, Inc.
Industry
Enrollment
228 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 14, 2022 (Actual)
Primary completion
May 20, 2026 (Actual)
Completion
Jun 3, 2026 (Actual)
Last update posted
Jun 26, 2026

2022 – 2026

United States locations

U.S. sites
37
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Adobe Clinical Research, LLC Tucson Arizona 85712 —
Arizona Liver Health Tucson Arizona 85712 —
Arcare Center for Clinical Research Little Rock Arkansas 72205 —
Clinical Trials Research Lincoln California 95648 —
United Clinical Research Institute Los Alamitos California 90720 —
Velocity Clinical Research Los Angeles California 90057 —
Alliance Clinical Research Poway California 92064 —
Nature Coast Clinical Research, LLC Inverness Florida 34452 —
ENCORE Borland Groover Clinical Research Jacksonville Florida 32256 —
Miami Clinical Research Miami Florida 33155 —
Ocala GI Research Ocala Florida 34471 —
Sensible Healthcare Clinical Research, LLC Ocoee Florida 34761 —
Centricity Research Columbus Georgia 31904 —
Gastrointestinal Specialists of Georgia, PC Marietta Georgia 30060 —
Iowa Digestive Disease Center Clive Iowa 50325 —
Tandem Clinical Research, LLC Marrero Louisiana 70072 —
Mid-Atlantic GI Research, LLC Greenbelt Maryland 20770 —
Boston Medical Center Boston University Chobanian & Avedisian School of Medicine Boston Massachusetts 02118 —
University of Michigan Ann Arbor Michigan 48109 —
GI Alliance Research Flowood Mississippi 39232 —
GI Associates Research, LLC Columbia Missouri 65201 —
Jefferson City Medical Group Jefferson City Missouri 65109 —
Lucas Research, Inc. Morehead City North Carolina 28557 —
DSI Research Northridge, LLC Dayton Ohio 45414 —
Penn State Health/Penn State College of Medicine Hershey Pennsylvania 17033 —
GI Alliance Research Cedar Park Texas 78613 —
GI Alliance Research Dallas Texas 75246 —
GI Alliance Research Garland Texas 75044 —
GLRI McAllen Research Pharr Texas 78577 —
Northeast Clinical Rsearch of San Antonio San Antonio Texas 78233 —
Endeavor Clinical Trials San Antonio Texas 78240 —
Impact Research Institute Waco Texas 76710 —
Digestive Health Research of Central Texas, LLC Waco Texas 76712 —
North Richmond Health Research Richmond Virginia 23229 —
GI Select Health Research Richmond Virginia 23236 —
Centricity Suffolk Virginia 23435 —
Liver Institute Northwest Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05327127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2026 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05327127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →